Prognostic analysis of CD5 expression in double-hit diffuse large B-cell lymphoma and effectiveness comparison in patients treated with dose-adjusted EPOCH plus rituximab/R-CHOP regimens

OBJECTIVES: To compare the efficacy of rituximab, dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide and doxorubicin (DA-EPOCH-R) with traditional rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP) regimens in CD5+ double-hit lymphoma (DHL) and to evaluate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Blood Lymphat Cancer
Main Authors: Zhang, Fangwen, Li, Ling, Zhang, Lei, Li, Xin, Fu, Xiaorui, Wang, Xinhua, Wu, Jingjing, Sun, Zhenchang, Kong, Fei, Ren, Liangliang, Zhang, Mingzhi
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6707937/
https://ncbi.nlm.nih.gov/pubmed/31692510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S216292
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados